The relationship between the quantitative evaluation of thyroid bed uptake and the disappearance of accumulation in adjuvant radioactive iodine therapy for differentiated thyroid cancer

被引:8
|
作者
Konishi, Kenta [1 ]
Ishiba, Ryo [1 ]
Ikenohira, Tsutomu [1 ]
Asao, Tomoyuki [1 ]
Hirata, Masanori [1 ]
Ohira, Keiichi [1 ]
Komatsu, Tetsuya [1 ]
Sawada, Michifumi [2 ]
Tanahashi, Yukichi [3 ]
Goshima, Satoshi [3 ]
Magata, Yasuhiro [4 ]
Nakamura, Katsumasa [1 ]
机构
[1] Hamamatsu Univ Sch Med, Dept Radiat Oncol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka, Japan
[2] Hamamatsu Univ Sch Med, Dept Radiol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka, Japan
[3] Hamamatsu Univ Sch Med, Dept Diagnost Radiol & Nucl Med, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka, Japan
[4] Hamamatsu Univ Sch Med, Preeminent Med Photon Educ & Res Ctr, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka, Japan
关键词
Thyroid cancer; Radioactive iodine therapy; Adjuvant therapy; Quantitative evaluation; Absolute radioactivity concentration; CARCINOMA; ABLATION;
D O I
10.1007/s12149-020-01546-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective Iodine-131 (I-131) radioactive iodine therapy (RAI) after total thyroidectomy is the standard treatment for patients with differentiated thyroid cancer (DTC). We investigated the relationship between the quantitative parameters of the iodine uptake and the disappearance of the accumulation in the thyroid bed in adjuvant therapy using a 1.11 GBq or 3.70 GBq dose of I-131. Methods We retrospectively analyzed the cases of 40 patients with DTC who were treated with RAI at our institution between April 2017 and August 2019. The patients were treated with the I-131 dose of 1.11 GBq (n = 25) or 3.70 GBq (n = 15) after total thyroidectomy. The I-131 whole-body scan and hybrid single-photon emission computed tomography/X-ray computed tomography (SPECT/CT) were performed 3 days after RAI. Using image analysis software, we measured the standardized uptake value (SUV) and absolute radioactivity concentration (kBq/ml) on the target lesions with the highest uptake in the thyroid bed. Results The median period from RAI to the evaluation of the absence of uptake of the thyroid bed was 6.75 months. After RAI, uptake of the thyroid bed disappeared in 26 of the 40 patients. The disappearance rate was significantly higher in the 3.70 GBq group than in the 1.11 GBq group (86.7% vs. 52.0%, respectively; p = 0.029). However, there were no significant differences in the values of kBq/ml or SUV between the 1.11 GBq group and 3.70 GBq group. On the other hand, the group in which the uptake disappeared after RAI showed significantly higher kBq/ml max and kBq/ml mean values than the group in which the uptake did not disappear after RAI (p = 0.028, p = 0.032, respectively). The SUVmax and SUVmean also tended to be higher in the disappeared-uptake group than the not-disappeared-uptake group, but the differences were not significant (p = 0.166, p = 0.176, respectively). Conclusions The quantitative evaluation might be useful as one of the predictive indicators of the disappearance of the accumulation of radioactive iodine in the thyroid bed.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 50 条
  • [21] Causes of False-Positive Radioactive Iodine Uptake in Patients with Differentiated Thyroid Cancer
    Karin Wu
    Uzoezi Ozomaro
    Robert Flavell
    Miguel Pampaloni
    Chienying Liu
    Current Radiology Reports, 9
  • [22] Challenges in the evaluation and management of radioactive iodine-refractory differentiated thyroid cancer
    Genco, Matthew T.
    Yaqub, Abid
    Jana, Suman
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (07) : 743 - 745
  • [23] Impact of molecular therapy on radioactive iodine uptake in patients with oncogene-driven metastatic differentiated thyroid cancer
    Yang, Adeline T.
    Segers, Blair
    Caradonio, Olivia
    Behl, Supriya
    Li, Yimei
    Zhuang, Hongming
    States, Lisa
    Mahajan, Priya
    Ketterl, Tyler Garrett
    Waguespack, Steven G.
    Isaza, Amber
    Sisko, Lindsay
    Franco, Aime
    Bauer, Andrew J.
    Laetsch, Theodore Willis
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Experiences of low iodine diets in the treatment of differentiated thyroid cancer with radioactive iodine ablation therapy
    Herbert, Georgia
    Searle, Aidan
    England, Clare Yvonne
    Ness, Andy
    Beasley, Matthew
    Haupt-Schott, Ingrid
    Moss, Laura
    Wescott, Judith
    Atkinson, Charlotte
    CLINICAL NUTRITION ESPEN, 2020, 39 : 190 - 197
  • [25] Adjuvant Radioactive Iodine Use Among Differentiated Thyroid Cancer Patients in the Military Health System
    Gill, Abegail A.
    Enewold, Lindsey
    Zahm, Shelia H.
    Shriver, Craig D.
    Zheng, Li
    McGlynn, Katherine A.
    Zhu, Kangmin
    MILITARY MEDICINE, 2014, 179 (09) : 1043 - 1050
  • [26] THYROID CANCER AFTER RADIOACTIVE IODINE THERAPY
    JACKSON, GL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 228 (03): : 290 - 290
  • [27] RADIOACTIVE IODINE THERAPY IN THYROID-CANCER
    BENUA, RS
    YEH, SDJ
    LEEPER, RD
    JOURNAL OF NUCLEAR MEDICINE, 1982, 23 (05) : P88 - P88
  • [28] Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy
    Arnoldo Piccardo
    Matteo Puntoni
    Gianluca Bottoni
    Giorgio Treglia
    Luca Foppiani
    Mattia Bertoli
    Ugo Catrambone
    Anselmo Arlandini
    Bassam Dib
    Vania Altrinetti
    Michela Massollo
    Irene Bossert
    Manlio Cabria
    Francesco Bertagna
    Luca Giovanella
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 926 - 934
  • [29] Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy
    Piccardo, Arnoldo
    Puntoni, Matteo
    Bottoni, Gianluca
    Treglia, Giorgio
    Foppiani, Luca
    Bertoli, Mattia
    Catrambone, Ugo
    Arlandini, Anselmo
    Dib, Bassam
    Altrinetti, Vania
    Massollo, Michela
    Bossert, Irene
    Cabria, Manlio
    Bertagna, Francesco
    Giovanella, Luca
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (06) : 926 - 934
  • [30] The Relationship Between Extent of Thyroid Cancer Surgery and Use of Radioactive Iodine
    Haymart, Megan R.
    Banerjee, Mousumi
    Yang, Di
    Stewart, Andrew K.
    Doherty, Gerard M.
    Koenig, Ronald J.
    Griggs, Jennifer J.
    ANNALS OF SURGERY, 2013, 258 (02) : 354 - 358